New York State Common Retirement Fund
VRNA

New York State Common Retirement Fund’s Verona Pharma VRNA Stock Holding History

New York State Common Retirement Fund’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-21,939
Closed -$2.07M – 3234
2025
Q2 		$2.07M Buy
21,939
+6,564
+43% +$486K ﹤0.01% 1396
2025
Q1 		$976K Buy
15,375
+9,232
+150% +$552K ﹤0.01% 1636
2024
Q4 		$285K Buy
+6,143
New +$231K ﹤0.01% 2146
2024
Q1 		– Sell
-29,669
Closed -$590K – 3254
2023
Q4 		$590K Buy
29,669
+3,716
+14% +$54.9K ﹤0.01% 2033
2023
Q3 		$423K Hold
25,953
– – ﹤0.01% 2126
2023
Q2 		$549K Buy
25,953
+18,832
+264% +$402K ﹤0.01% 2044
2023
Q1 		$143K Buy
+7,121
New +$154K ﹤0.01% 2717

Other funds holding VRNA

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

New York State Common Retirement Fund's VRNA Position: Q3 2025 in Review

New York State Common Retirement Fund sold out of Verona Pharma (VRNA) in Q3 2025, closing a stake of 21,939 shares — an estimated $2.07M sold.

New York State Common Retirement Fund first reported a position in VRNA in Q1 2023 and held it in 7 quarters. The position peaked at $2.07M in Q2 2025. 243 funds tracked by Wall St. Rank hold VRNA as of Q3 2025.

  • New York State Common Retirement Fund reported no remaining Verona Pharma position as of Q3 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 21,939 Verona Pharma shares in Q3 2025, an estimated $2.07M.
  • New York State Common Retirement Fund first reported a position in Verona Pharma in Q1 2023 and held it in 7 quarters.
  • New York State Common Retirement Fund's Verona Pharma position peaked at $2.07M in Q2 2025.
  • 243 funds tracked by Wall St. Rank held Verona Pharma as of Q3 2025.

Based on New York State Common Retirement Fund's 13F filing for Q3 2025, filed 3 Nov 2025.